Towards its journey of profitable growth and technological advancement & strengthening the company, various process as well as polymorph patent applications have been filed by Morepen for various products like Rosuvastatin calcium, Sitagliptin Phosphate, Fexofenadine Hydrochloride, Loratadine, Atorvastatin calcium. Morepen has developed New polymorphs of Rosuvastatin calcium and Sitagliptin Phosphate followed by filing of their polymorph patents. Rosuvastatin calcium & Sitagliptin Phosphate have also been commercialized. The COS for Rosuvastatin has been filed whereas COS filing for Sitagliptin is planned for the current year. Apart from this, anti-hypersensitive drug Olmesartan Medoxomil has also been commercialized.
New Delhi, India
